Myriad Genetics Inc (NASDAQ:MYGN)

34.57
Delayed Data
As of Jul 02
 +0.23 / +0.67%
Today’s Change
31.34
Today|||52-Week Range
40.50
+1.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line100.7M112.2M147.1M176.2M
 
 
 
 
 
Depreciation7.2M9.1M8.9M13.8M
 
 
 
 
 
Total Other Cash Flow-15.7M15.8M51.4M52.0M
 
 
 
 
 
Funds From Operations145.4M170.6M214.9M250.2M
 
 
 
 
 
Funds From/For Other Operating Expenses14.6M28.8M41.0M60.0M
 
 
 
 
 
Net Cash Flow - Operating Activities130.8M141.8M173.9M190.2M
 
 
 
 
 
 
InvestingIncrease In Investments-425.2M-388.1M-448.8M-385.3M
 
 
 
 
 
Decrease In Investments456.1M385.2M384.6M381.9M
 
 
 
 
 
Capital Expenditures-3.8M-9.4M-11.4M-14.3M
 
 
 
 
 
Net Assets From Acquisitions -79.4M-799.0K0.000.00
 
 
 
Other Investing - Uses0.00-25.1M0.000.00
 
 
Net Cash Flow Investing-54.4M-38.9M-75.6M-17.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale25.1M25.0M57.8M64.8M
 
 
 
 
 
Common Preferred Redeemed-200.5M-128.5M-146.3M-287.7M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing58.8M34.2M7.9M11.1M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-116.6M-69.2M-80.6M-211.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash71.0K-42.0K0.000.00
 
 
 
 
Net Change In Cash-40.2M33.7M17.7M-39.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account